Inflammation, etiologies and MELD-score - What makes liver disease patients susceptible to developing colorectal neoplasia?
Research has identified patients with chronic liver disease as risk-group for colorectal neoplasia. In this study, we aimed to identify liver disease sub-groups at enhanced risk to develop colorectal neoplasia as well as causal factors. Our retrospective study includes patients with chronic liver disease (LDPs) undergoing colonoscopy during liver transplantation evaluations, and liver-healthy patients (LHPs) as part of the German screening protocol. We assessed inflammatory lab values, model for end-stage liver disease (MELD)-score, portal hypertension and liver disease etiologies as explanatory variables. Outcomes included polyps, adenomas, high-risk situations and colorectal cancer, tested in uni- and multivariable analyses. 1,046 patients were included, 407 with liver disease, 639 without. Alcohol-toxic, metabolic, cryptogenic, non-alcoholic fatty liver disease, and hepatocellular carcinoma were significantly associated with colorectal neoplasia, as were low compared to high MELD-scores. Portal hypertension showed no associations with neoplasia. Inflammatory markers were associated with colorectal neoplasia, independent of liver-disease severity. Low MELD-score, inflammatory markers and certain etiologies were associated with colorectal neoplasia. Our findings suggest that inflammation may play an important role for the development of colonic adenomas in LDPs. Findings need to be confirmed in prospective studies but may allow risk-stratification and, possibly, development of prophylactic treatments.